期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Norepinephrine:the next therapeutics frontier for Parkinson’s disease 被引量:4
1
作者 peter a lewitt 《Translational Neurodegeneration》 SCIE CAS 2012年第1期20-23,共4页
Tissue concentrations of norepinephrine(NE)are markedly decreased in various regions of the Parkinson’s disease(PD)brain.As in the substantia nigra pars compacta,neuronal dropout and Lewy bodies are prominent changes... Tissue concentrations of norepinephrine(NE)are markedly decreased in various regions of the Parkinson’s disease(PD)brain.As in the substantia nigra pars compacta,neuronal dropout and Lewy bodies are prominent changes affecting the locus coeruleus,which is the source of ascending NErgic projections.Despite the major roles of NE throughout the brain,there has been only minimal exploration of pharmacological intervention with NErgic neurotransmission.Cognitive operations,“freezing”of gait,tremor,dyskinesia,REM sleep regulation,and other aspects of brain function are tied into signaling by NE,and there is also evidence that it may have a role in the neurodegenerative process itself.This article reviews the reported pharmacological experience in PD therapeutics. 展开更多
关键词 NOREPINEPHRINE Parkinson??s disease NEUROPHARMACOLOGY
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部